Skip to content
Back to INSM

Insmed Inc

Open-market purchases and sales reported on SEC Forms 4 and 5, with each filing and its footnotes.

Since Nov 18, 2025
Transactions
147
Purchases
0
Sales
147
Purchase value
$0.00
Sale value
$133.74M

Values are shares multiplied by reported price when both were supplied, each trade counted once however many filers reported it.

David R BrennanDirector
4
Filed Sep 11, 2026Period of report Sep 9, 20260001609305-26-000009
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleSep 9, 2026
Common Stock25,000$124.00$3.10M39,238Direct
Open on SEC EDGAR
Melvin MD SharokyDirector
4
Filed Aug 19, 2026Period of report Aug 17, 20260001182633-26-000010
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleAug 17, 2026
Common StockF1F25,000$127.53$637.65K0IndirectBy Padonia, LLC
Filing footnotes · 6
  1. F1This is the weighted average sales price representing 5,000 shares sold at prices ranging from $127.51 to $127.61 per share. The Reporting Person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.
  2. F2The Reporting Person is the managing member of Padonia, LLC.
  3. F3The Reporting Person is the custodian of Melvin Sharoky C/F Adler J. Wink UTMA/FL.
  4. F4The Reporting Person is the custodian of Melvin Sharoky C/F Nolan M. Wink UTMA/FL.
  5. F5The Reporting Person is the custodian of Melvin Sharoky C/F Sophie C. Wink UTMA/FL.
  6. F6The Reporting Person is the custodian of Melvin Sharoky C/F Tulia L. Sharoky UTMA/FL.
Open on SEC EDGAR
Roger AdsettChief Operating Officer
4
Filed Aug 12, 2026Period of report Aug 10, 20260001685904-26-000014
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleAug 10, 2026
Common StockF2239,850$133.27$31.96M98,744Direct
Filing footnotes · 3
  1. F1Includes 141 shares acquired through the Company's 2018 Employee Stock Purchase Plan.
  2. F2This is the weighted average sales price representing 239,850 shares sold at prices ranging from $133.00 to $133.51 per share. The Reporting Person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.
  3. F3The options became exercisable based on the following vesting schedule: 25% vested on the first anniversary of the grant date and an additional 12.5% vested on each sixth month anniversary date thereafter through the fourth anniversary of the date of grant.
Open on SEC EDGAR
Martina M.D. FlammerChief Medical Officer
4Rule 10b5-1 plan disclosed
Filed Aug 7, 2026Period of report Aug 6, 20260001796960-26-000020
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleAug 6, 2026
Common StockF18,895$127.00$1.13M78,764Direct
SaleAug 6, 2026
Common StockF1F218,278$129.40$2.37M60,486Direct
Filing footnotes · 4
  1. F1This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on February 27, 2025 in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended.
  2. F2This is the weighted average sales price representing 18,278 shares sold at prices ranging from $129.40 to $129.41 per share. The Reporting Person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.
  3. F3The options become exercisable based on the following vesting schedule: 25% vest on the first anniversary of the grant date and an additional 12.5% vest on each sixth month anniversary date thereafter through the fourth anniversary of the date of grant.
  4. F4The options become exercisable based on the following vesting schedule: 25% vest on the first day of the first month following the first anniversary of the date of grant (the Initial Vesting Date) and 12.5% vest on each sixth month anniversary date thereafter through the fourth anniversary of the Initial Vesting Date.
Open on SEC EDGAR
William LewisDirector · Chair and CEO
4Rule 10b5-1 plan disclosed
Filed Jul 24, 2026Period of report Jul 23, 20260001402051-26-000042
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleJul 23, 2026
Common StockF1F24,828$105.62$509.93K264,930Direct
SaleJul 23, 2026
Common StockF1F35,872$106.43$624.96K259,058Direct
Filing footnotes · 4
  1. F1This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on September 4, 2025, in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended.
  2. F2This is the weighted average sales price representing 4,828 shares sold at prices ranging from $105.09 to $106.02 per share. The Reporting Person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.
  3. F3This is the weighted average sales price representing 5,872 shares sold at prices ranging from $106.09 to $106.78 per share. The Reporting Person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.
  4. F4The options became exercisable based on the following vesting schedule: 25% vested on the first anniversary of the grant date and an additional 12.5% vested on each sixth month anniversary date thereafter through the fourth anniversary of the date of grant.
Open on SEC EDGAR
William LewisDirector · Chair and CEO
4Rule 10b5-1 plan disclosed
Filed Jul 10, 2026Period of report Jul 9, 20260001402051-26-000040
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleJul 9, 2026
Common StockF1F35,005$116.55$583.33K264,752Direct
SaleJul 9, 2026
Common StockF1F42,335$117.62$274.64K262,417Direct
SaleJul 9, 2026
Common StockF1F53,359$118.52$398.11K259,058Direct
Filing footnotes · 6
  1. F1This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on September 4, 2025, in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended.
  2. F2Includes 141 shares acquired through the Company's 2018 Employee Stock Purchase Plan.
  3. F3This is the weighted average sales price representing 5,005 shares sold at prices ranging from $116.01 to $117.00 per share. The Reporting Person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.
  4. F4This is the weighted average sales price representing 2,335 shares sold at prices ranging from $117.05 to $117.96 per share. The Reporting Person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.
  5. F5This is the weighted average sales price representing 3,359 shares sold at prices ranging from $118.06 to $118.80 per share. The Reporting Person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.
  6. F6The options became exercisable based on the following vesting schedule: 25% vested on the first anniversary of the grant date and an additional 12.5% vested on each sixth month anniversary date thereafter through the fourth anniversary of the date of grant.
Open on SEC EDGAR
Martina M.D. FlammerChief Medical Officer
4Rule 10b5-1 plan disclosed
Filed Jul 8, 2026Period of report Jul 6, 20260001796960-26-000018
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleJul 6, 2026
Common StockF1F24,854$109.02$529.18K67,934Direct
SaleJul 6, 2026
Common StockF1F37,448$110.60$823.75K60,486Direct
Filing footnotes · 4
  1. F1This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on February 27, 2025 in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended.
  2. F2This is the weighted average sales price representing 4,854 shares sold at prices ranging from $108.90 to $109.58 per share. The Reporting Person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.
  3. F3This is the weighted average sales price representing 7,448 shares sold at prices ranging from $110.36 to $110.71 per share. The Reporting Person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.
  4. F4The options become exercisable based on the following vesting schedule: 25% vest on the first anniversary of the grant date and an additional 12.5% vest on each sixth month anniversary date thereafter through the fourth anniversary of the date of grant.
Open on SEC EDGAR
William LewisDirector · Chair and CEO
4Rule 10b5-1 plan disclosed
Filed Jun 26, 2026Period of report Jun 25, 20260001402051-26-000038
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleJun 25, 2026
Common StockF1F212,091$102.34$1.24M268,224Direct
SaleJun 25, 2026
Common StockF1F31,836$103.10$189.29K266,388Direct
SaleJun 25, 2026
Common StockF1F43,723$104.28$388.23K262,665Direct
SaleJun 25, 2026
Common StockF1F52,456$105.27$258.54K260,209Direct
SaleJun 25, 2026
Common StockF1F61,292$106.27$137.30K258,917Direct
Filing footnotes · 7
  1. F1This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on September 4, 2025, in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended.
  2. F2This is the weighted average sales price representing 12,091 shares sold at prices ranging from $101.78 to $102.77 per share. The Reporting Person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.
  3. F3This is the weighted average sales price representing 1,836 shares sold at prices ranging from $102.78 to $103.58 per share. The Reporting Person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.
  4. F4This is the weighted average sales price representing 3,723 shares sold at prices ranging from $103.87 to $104.75 per share. The Reporting Person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.
  5. F5This is the weighted average sales price representing 2,456 shares sold at prices ranging from $104.90 to $105.88 per share. The Reporting Person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.
  6. F6This is the weighted average sales price representing 1,292 shares sold at prices ranging from $105.90 to $106.45 per share. The Reporting Person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.
  7. F7The options became exercisable based on the following vesting schedule: 25% vested on the first anniversary of the grant date and an additional 12.5% vested on each sixth month anniversary date thereafter through the fourth anniversary of the date of grant.
Open on SEC EDGAR
Michael Alexander SmithChief Legal Officer
4Rule 10b5-1 plan disclosed
Filed Jun 24, 2026Period of report Jun 22, 20260001870278-26-000020
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleJun 22, 2026
Common StockF11,806$95.82$173.05K37,648Direct
Filing footnotes · 1
  1. F1This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on November 7, 2025, in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended.
Open on SEC EDGAR
William LewisDirector · Chair and CEO
4Rule 10b5-1 plan disclosed
Filed Jun 10, 2026Period of report Jun 8, 20260001402051-26-000035
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleJun 8, 2026
Common StockF16,515$94.03$612.61K258,917Direct
Filing footnotes · 1
  1. F1This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on September 4, 2025 in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended.
Open on SEC EDGAR
Martina M.D. FlammerChief Medical Officer
4Rule 10b5-1 plan disclosed
Filed Jun 5, 2026Period of report Jun 3, 20260001796960-26-000016
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleJun 5, 2026
Common StockF21,858$103.78$192.82K60,486Direct
SaleJun 3, 2026
Common StockF12,566$102.27$262.42K62,344Direct
Filing footnotes · 2
  1. F1Shares sold to satisfy tax withholding obligations upon the vesting of Restricted Stock Units and to cover related broker fees.
  2. F2This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on February 27, 2025 in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended.
Open on SEC EDGAR
Michael Alexander SmithChief Legal Officer
4
Filed Jun 5, 2026Period of report Jun 3, 20260001870278-26-000017
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleJun 3, 2026
Common StockF12,159$102.27$220.80K39,454Direct
Filing footnotes · 1
  1. F1Shares sold to satisfy tax withholding obligations upon the vesting of Restricted Stock Units and to cover related broker fees.
Open on SEC EDGAR
Roger AdsettChief Operating Officer
4
Filed Jun 5, 2026Period of report Jun 3, 20260001685904-26-000012
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleJun 3, 2026
Common StockF12,370$102.27$242.38K98,603Direct
Filing footnotes · 1
  1. F1Shares sold to satisfy tax withholding obligations upon the vesting of Restricted Stock Units and to cover related broker fees.
Open on SEC EDGAR
Sara BonsteinChief Financial Officer
4
Filed Jun 5, 2026Period of report Jun 3, 20260001604019-26-000010
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleJun 3, 2026
Common StockF12,404$102.27$245.86K69,082Direct
Filing footnotes · 1
  1. F1Shares sold to satisfy tax withholding obligations upon the vesting of Restricted Stock Units and to cover related broker fees.
Open on SEC EDGAR
William LewisDirector · Chair and CEO
4
Filed Jun 5, 2026Period of report Jun 3, 20260001402051-26-000032
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleJun 3, 2026
Common StockF17,605$102.27$777.76K265,432Direct
Filing footnotes · 1
  1. F1Shares sold to satisfy tax withholding obligations upon the vesting of Restricted Stock Units and to cover related broker fees.
Open on SEC EDGAR
Michael Alexander SmithChief Legal Officer
4Rule 10b5-1 plan disclosed
Filed May 22, 2026Period of report May 22, 20260001870278-26-000015
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleMay 22, 2026
Common StockF16,149$108.47$666.98K41,613Direct
Filing footnotes · 1
  1. F1This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on November 7, 2025, in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended.
Open on SEC EDGAR
William LewisDirector · Chair and CEO
4Rule 10b5-1 plan disclosed
Filed May 20, 2026Period of report May 18, 20260001402051-26-000030
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleMay 18, 2026
Common StockF1F25,753$105.32$605.91K292,848Direct
SaleMay 18, 2026
Common StockF1F311,836$106.39$1.26M281,012Direct
SaleMay 18, 2026
Common StockF1F47,975$106.97$853.09K273,037Direct
Filing footnotes · 5
  1. F1This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on September 4, 2025 in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended.
  2. F2This is the weighted average sales price representing 5,753 shares sold at prices ranging from $104.73 to $105.71 per share. The Reporting Person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.
  3. F3This is the weighted average sales price representing 11,836 shares sold at prices ranging from $105.73 to $106.72 per share. The Reporting Person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.
  4. F4This is the weighted average sales price representing 7,975 shares sold at prices ranging from $106.73 to $107.36 per share. The Reporting Person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.
  5. F5The options became exercisable based on the following vesting schedule: 25% vested on the first anniversary of the grant date and an additional 12.5% vested on each sixth month anniversary date thereafter through the fourth anniversary of the date of grant.
Open on SEC EDGAR
Martina M.D. FlammerChief Medical Officer
4Rule 10b5-1 plan disclosed
Filed May 15, 2026Period of report May 13, 20260001796960-26-000014
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleMay 14, 2026
Common StockF310,479$117.54$1.23M64,910Direct
SaleMay 13, 2026
Common StockF1F24,470$112.76$504.04K78,773Direct
SaleMay 13, 2026
Common StockF13,384$116.18$393.15K75,389Direct
Filing footnotes · 3
  1. F1Shares sold to satisfy tax withholding obligations upon the vesting of Restricted Stock Units and to cover related broker fees.
  2. F2This is the weighted average sales price representing 4,470 shares sold at prices ranging from $112.65 to $112.85 per share. The Reporting Person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.
  3. F3This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on February 27, 2025 in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended.
Open on SEC EDGAR
Michael Alexander SmithChief Legal Officer
4
Filed May 15, 2026Period of report May 13, 20260001870278-26-000012
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleMay 13, 2026
Common StockF14,109$116.18$477.38K47,762Direct
Filing footnotes · 1
  1. F1Shares sold to satisfy tax withholding obligations upon the vesting of Restricted Stock Units and to cover related broker fees.
Open on SEC EDGAR
Roger AdsettChief Operating Officer
4
Filed May 15, 2026Period of report May 13, 20260001685904-26-000010
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleMay 13, 2026
Common StockF15,837$116.18$678.14K100,973Direct
Filing footnotes · 1
  1. F1Shares sold to satisfy tax withholding obligations upon the vesting of Restricted Stock Units and to cover related broker fees.
Open on SEC EDGAR
Sara BonsteinChief Financial Officer
4
Filed May 15, 2026Period of report May 13, 20260001604019-26-000008
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleMay 13, 2026
Common StockF18,272$116.18$961.04K71,486Direct
Filing footnotes · 1
  1. F1Shares sold to satisfy tax withholding obligations upon the vesting of Restricted Stock Units and to cover related broker fees.
Open on SEC EDGAR
William LewisDirector · Chair and CEO
4
Filed May 15, 2026Period of report May 13, 20260001402051-26-000028
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleMay 13, 2026
Common StockF113,283$116.18$1.54M287,902Direct
Filing footnotes · 1
  1. F1Shares sold to satisfy tax withholding obligations upon the vesting of Restricted Stock Units and to cover related broker fees.
Open on SEC EDGAR
Martina M.D. FlammerChief Medical Officer
4Rule 10b5-1 plan disclosed
Filed May 13, 2026Period of report May 11, 20260001796960-26-000012
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleMay 11, 2026
Common StockF1F212,119$100.35$1.22M84,073Direct
SaleMay 11, 2026
Common StockF1F3830$101.18$83.98K83,243Direct
Filing footnotes · 4
  1. F1This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on February 27, 2025 in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended.
  2. F2This is the weighted average sales price representing 12,119 shares sold at prices ranging from $100.00 to $100.96 per share. The Reporting Person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.
  3. F3This is the weighted average sales price representing 830 shares sold at prices ranging from $101.11 to $101.36 per share. The Reporting Person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.
  4. F4The options became exercisable based on the following vesting schedule: 25% vested on the first anniversary of the grant date and an additional 12.5% vested on each sixth month anniversary date thereafter through the fourth anniversary of the date of grant.
Open on SEC EDGAR
William LewisDirector · Chair and CEO
4Rule 10b5-1 plan disclosed
Filed May 6, 2026Period of report May 4, 20260001402051-26-000026
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleMay 4, 2026
Common StockF1F2433$134.18$58.10K311,451Direct
SaleMay 4, 2026
Common StockF1F3599$135.18$80.97K310,852Direct
SaleMay 4, 2026
Common StockF1F45,318$137.01$728.62K305,534Direct
SaleMay 4, 2026
Common StockF1F52,721$137.86$375.12K302,813Direct
SaleMay 4, 2026
Common StockF1F61,247$139.09$173.45K301,566Direct
SaleMay 4, 2026
Common StockF1381$139.60$53.19K301,185Direct
Filing footnotes · 7
  1. F1This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on September 4, 2025 in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended.
  2. F2This is the weighted average sales price representing 433 shares sold at prices ranging from $133.88 to $134.69 per share. The Reporting Person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.
  3. F3This is the weighted average sales price representing 599 shares sold at prices ranging from $135.06 to $135.50 per share. The Reporting Person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.
  4. F4This is the weighted average sales price representing 5,318 shares sold at prices ranging from $136.32 to $137.30 per share. The Reporting Person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.
  5. F5This is the weighted average sales price representing 2,721 shares sold at prices ranging from $137.32 to $138.28 per share. The Reporting Person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.
  6. F6This is the weighted average sales price representing 1,247 shares sold at prices ranging from $138.52 to $139.43 per share. The Reporting Person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.
  7. F7The options became exercisable based on the following vesting schedule: 25% vested on the first anniversary of the grant date and an additional 12.5% vested on each sixth month anniversary date thereafter through the fourth anniversary of the date of grant.
Open on SEC EDGAR
William LewisDirector · Chair and CEO
4Rule 10b5-1 plan disclosed
Filed Apr 17, 2026Period of report Apr 16, 20260001402051-26-000024
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleApr 16, 2026
Common StockF1F22,246$142.99$321.16K309,638Direct
SaleApr 16, 2026
Common StockF1F35,373$143.81$772.69K304,265Direct
SaleApr 16, 2026
Common StockF1F42,255$144.66$326.21K302,010Direct
SaleApr 16, 2026
Common StockF1F5825$145.79$120.28K301,185Direct
Filing footnotes · 6
  1. F1This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on September 4, 2025 in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended.
  2. F2This is the weighted average sales price representing 2,246 shares sold at prices ranging from $142.39 to $143.38 per share. The Reporting Person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.
  3. F3This is the weighted average sales price representing 5,373 shares sold at prices ranging from $143.39 to $144.32 per share. The Reporting Person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.
  4. F4This is the weighted average sales price representing 2,255 shares sold at prices ranging from $144.40 to $145.20 per share. The Reporting Person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.
  5. F5This is the weighted average sales price representing 825 shares sold at prices ranging from $145.53 to $146.02 per share. The Reporting Person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.
  6. F6The options became exercisable based on the following vesting schedule: 25% vested on the first anniversary of the grant date and an additional 12.5% vested on each sixth month anniversary date thereafter through the fourth anniversary of the date of grant.
Open on SEC EDGAR
William LewisDirector · Chair and CEO
4Rule 10b5-1 plan disclosed
Filed Apr 8, 2026Period of report Apr 6, 20260001402051-26-000022
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleApr 6, 2026
Common StockF1F2787$161.73$127.28K311,097Direct
SaleApr 6, 2026
Common StockF1F38,478$163.23$1.38M302,619Direct
SaleApr 6, 2026
Common StockF1F41,434$164.01$235.19K301,185Direct
Filing footnotes · 5
  1. F1This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on September 4, 2025 in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended.
  2. F2This is the weighted average sales price representing 787 shares sold at prices ranging from $161.65 to $162.58 per share. The Reporting Person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.
  3. F3This is the weighted average sales price representing 8,478 shares sold at prices ranging from $162.66 to $163.65 per share. The Reporting Person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.
  4. F4This is the weighted average sales price representing 1,434 shares sold at prices ranging from $163.66 to $164.36 per share. The Reporting Person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.
  5. F5The options became exercisable based on the following vesting schedule: 25% vested on the first anniversary of the grant date and an additional 12.5% vested on each sixth month anniversary date thereafter through the fourth anniversary of the date of grant.
Open on SEC EDGAR
Roger AdsettChief Operating Officer
4Rule 10b5-1 plan disclosed
Filed Apr 3, 2026Period of report Apr 1, 20260001685904-26-000008
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleApr 1, 2026
Common StockF1F26,715$163.18$1.10M188,155Direct
SaleApr 1, 2026
Common StockF1F319,001$164.11$3.12M169,154Direct
SaleApr 1, 2026
Common StockF1F462,344$164.95$10.28M106,810Direct
Filing footnotes · 5
  1. F1This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on December 3, 2025, in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended.
  2. F2This is the weighted average sales price representing 6,715 shares sold at prices ranging from $162.52 to $163.51 per share. The Reporting Person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.
  3. F3This is the weighted average sales price representing 19,001 shares sold at prices ranging from $163.52 to $164.51 per share. The Reporting Person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.
  4. F4This is the weighted average sales price representing 62,344 shares sold at prices ranging from $164.52 to $165.45 per share. The Reporting Person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.
  5. F5The options became exercisable based on the following vesting schedule: 25% vested on the first anniversary of the grant date and an additional 12.5% vested on each sixth month anniversary date thereafter through the fourth anniversary of the date of grant.
Open on SEC EDGAR
Michael Alexander SmithChief Legal Officer
4Rule 10b5-1 plan disclosed
Filed Mar 31, 2026Period of report Mar 30, 20260001870278-26-000010
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleMar 30, 2026
Common StockF119,638$150.98$2.96M51,871Direct
Filing footnotes · 3
  1. F1This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on November 7, 2025, in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended.
  2. F2The options become exercisable based on the following vesting schedule: 25% vest on the first anniversary of the grant date and an additional 12.5% vest on each sixth month anniversary date thereafter through the fourth anniversary of the date of grant.
  3. F3The options became exercisable based on the following vesting schedule: 25% vested on the first anniversary of the grant date and an additional 12.5% vested on each sixth month anniversary date thereafter through the fourth anniversary of the date of grant.
Open on SEC EDGAR
William LewisDirector · Chair and CEO
4Rule 10b5-1 plan disclosed
Filed Mar 20, 2026Period of report Mar 19, 20260001402051-26-000020
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleMar 19, 2026
Common StockF1F21,629$142.17$231.59K310,255Direct
SaleMar 19, 2026
Common StockF1F34,537$143.42$650.70K305,718Direct
SaleMar 19, 2026
Common StockF1F44,533$144.11$653.25K301,185Direct
Filing footnotes · 5
  1. F1This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on September 4, 2025 in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended.
  2. F2This is the weighted average sales price representing 1,629 shares sold at prices ranging from $141.80 to $142.74 per share. The Reporting Person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.
  3. F3This is the weighted average sales price representing 4,537 shares sold at prices ranging from $142.80 to $143.77 per share. The Reporting Person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.
  4. F4This is the weighted average sales price representing 4,533 shares sold at prices ranging from $143.80 to $144.72 per share. The Reporting Person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.
  5. F5The options became exercisable based on the following vesting schedule: 25% vested on the first anniversary of the grant date and an additional 12.5% vested on each sixth month anniversary date thereafter through the fourth anniversary of the date of grant.
Open on SEC EDGAR
William LewisDirector · Chair and CEO
4Rule 10b5-1 plan disclosed
Filed Mar 5, 2026Period of report Mar 5, 20260001402051-26-000018
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleMar 5, 2026
Common StockF1F22,083$144.23$300.43K309,801Direct
SaleMar 5, 2026
Common StockF1F32,589$145.27$376.10K307,212Direct
SaleMar 5, 2026
Common StockF1F43,899$146.66$571.83K303,313Direct
SaleMar 5, 2026
Common StockF1F5F62,128$147.54$313.97K301,185Direct
Filing footnotes · 7
  1. F1This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on September 4, 2025 in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended.
  2. F2This is the weighted average sales price representing 2,083 shares sold at prices ranging from $143.84 to $144.70 per share. The Reporting Person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.
  3. F3This is the weighted average sales price representing 2,589 shares sold at prices ranging from $144.99 to $145.78 per share. The Reporting Person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.
  4. F4This is the weighted average sales price representing 3,899 shares sold at prices ranging from $146.09 to $147.06 per share. The Reporting Person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.
  5. F5This is the weighted average sales price representing 2,128 shares sold at prices ranging from $147.15 to $148.04 per share. The Reporting Person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.
  6. F6The Reporting Person no longer has a reportable beneficial interest in the securities owned by the William Lewis Family Legacy Trust, which were included in the Reporting Person's prior ownership reports.
  7. F7The options became exercisable based on the following vesting schedule: 25% vested on the first anniversary of the grant date and an additional 12.5% vested on each sixth month anniversary date thereafter through the fourth anniversary of the date of grant.
Open on SEC EDGAR
Michael Alexander SmithChief Legal Officer
4Rule 10b5-1 plan disclosed
Filed Feb 25, 2026Period of report Feb 24, 20260001870278-26-000008
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleFeb 24, 2026
Common StockF1F24,852$153.93$746.87K71,793Direct
SaleFeb 24, 2026
Common StockF1F34,151$155.06$643.65K67,642Direct
SaleFeb 24, 2026
Common StockF1F415,771$156.53$2.47M51,871Direct
Filing footnotes · 5
  1. F1This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on November 7, 2025 in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended.
  2. F2This is the weighted average sales price representing 4,852 shares sold at prices ranging from $153.47 to $154.46 per share. The Reporting Person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.
  3. F3This is the weighted average sales price representing 4,151 shares sold at prices ranging from $154.47 to $155.45 per share. The Reporting Person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.
  4. F4This is the weighted average sales price representing 15,771 shares sold at prices ranging from $156.00 to $156.86 per share. The Reporting Person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.
  5. F5The options become exercisable based on the following vesting schedule: 25% vest on the first anniversary of the grant date and an additional 12.5% vest on each sixth month anniversary date thereafter through the fourth anniversary of the date of grant.
Open on SEC EDGAR
William LewisDirector · Chair and CEO
4Rule 10b5-1 plan disclosed
Filed Feb 23, 2026Period of report Feb 19, 20260001402051-26-000015
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleFeb 19, 2026
Common StockF1F21,988$149.17$296.55K309,896Direct
SaleFeb 19, 2026
Common StockF1F31,891$150.10$283.84K308,005Direct
SaleFeb 19, 2026
Common StockF1F43,413$151.12$515.77K304,592Direct
SaleFeb 19, 2026
Common StockF1F52,377$151.92$361.11K302,215Direct
SaleFeb 19, 2026
Common StockF1F61,030$153.38$157.98K301,185Direct
Filing footnotes · 7
  1. F1This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on September 4, 2025 in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended.
  2. F2This is the weighted average sales price representing 1,988 shares sold at prices ranging from $148.51 to $149.50 per share. The Reporting Person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.
  3. F3This is the weighted average sales price representing 1,891 shares sold at prices ranging from $149.53 to $150.50 per share. The Reporting Person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.
  4. F4This is the weighted average sales price representing 3,413 shares sold at prices ranging from $150.54 to $151.51 per share. The Reporting Person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.
  5. F5This is the weighted average sales price representing 2,377 shares sold at prices ranging from $151.56 to $152.43 per share. The Reporting Person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.
  6. F6This is the weighted average sales price representing 1,030 shares sold at prices ranging from $153.00 to $153.78 per share. The Reporting Person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.
  7. F7The options became exercisable based on the following vesting schedule: 25% vested on the first anniversary of the grant date and an additional 12.5% vested on each sixth month anniversary date thereafter through the fourth anniversary of the date of grant.
Open on SEC EDGAR
William LewisDirector · Chair and CEO
4Rule 10b5-1 plan disclosed
Filed Feb 11, 2026Period of report Feb 9, 20260001402051-26-000013
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleFeb 9, 2026
Common StockF1F24,888$147.17$719.37K309,693Direct
SaleFeb 9, 2026
Common StockF1F37,221$148.02$1.07M302,472Direct
SaleFeb 9, 2026
Common StockF1F41,287$148.83$191.54K301,185Direct
Filing footnotes · 5
  1. F1This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on September 4, 2025 in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended.
  2. F2This is the weighted average sales price representing 4,888 shares sold at prices ranging from $146.61 to $147.60 per share. The Reporting Person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.
  3. F3This is the weighted average sales price representing 7,221 shares sold at prices ranging from $147.61 to $148.60 per share. The Reporting Person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.
  4. F4This is the weighted average sales price representing 1,287 shares sold at prices ranging from $148.62 to $149.35 per share. The Reporting Person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.
  5. F5The options became exercisable based on the following vesting schedule: 25% vested on the first anniversary of the grant date and an additional 12.5% vested on each sixth month anniversary date thereafter through the fourth anniversary of the date of grant.
Open on SEC EDGAR
Martina M.D. FlammerChief Medical Officer
4Rule 10b5-1 plan disclosed
Filed Feb 6, 2026Period of report Feb 5, 20260001796960-26-000010
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleFeb 5, 2026
Common StockF1869$152.44$132.47K83,243Direct
Filing footnotes · 1
  1. F1This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on February 27, 2025 in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended.
Open on SEC EDGAR
Michael Alexander SmithChief Legal Officer
4
Filed Feb 4, 2026Period of report Feb 3, 20260001870278-26-000006
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleFeb 3, 2026
Common StockF1640$156.27$100.01K56,397Direct
Filing footnotes · 1
  1. F1Shares sold to satisfy tax withholding obligations upon the vesting of Restricted Stock Units and to cover related broker fees.
Open on SEC EDGAR
Martina M.D. FlammerChief Medical Officer
4Rule 10b5-1 plan disclosed
Filed Feb 4, 2026Period of report Feb 2, 20260001796960-26-000008
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleFeb 3, 2026
Common StockF6795$155.77$123.84K84,112Direct
SaleFeb 2, 2026
Common StockF1F2563$152.06$85.61K92,326Direct
SaleFeb 2, 2026
Common StockF1F3928$153.16$142.13K91,398Direct
SaleFeb 2, 2026
Common StockF1F43,349$154.56$517.62K88,049Direct
SaleFeb 2, 2026
Common StockF1F53,042$155.46$472.91K85,007Direct
SaleFeb 2, 2026
Common StockF1100$156.86$15.69K84,907Direct
Filing footnotes · 7
  1. F1This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on February 27, 2025 in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended.
  2. F2This is the weighted average sales price representing 563 shares sold at prices ranging from $151.76 to $152.74 per share. The Reporting Person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.
  3. F3This is the weighted average sales price representing 928 shares sold at prices ranging from $152.77 to $153.31 per share. The Reporting Person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.
  4. F4This is the weighted average sales price representing 3,349 shares sold at prices ranging from $154.10 to $155.09 per share. The Reporting Person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.
  5. F5This is the weighted average sales price representing 3,042 shares sold at prices ranging from $155.10 to $155.96 per share. The Reporting Person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.
  6. F6Shares sold to satisfy tax withholding obligations upon the vesting of Restricted Stock Units and to cover related broker fees.
  7. F7These stock options were granted under the Company's Amended and Restated 2019 Incentive Plan, as amended. The options become exercisable based on the following vesting schedule: 25% vest on the first day of the first month following the first anniversary of the date of grant and an additional 12.5% vest every six months thereafter until fully vested.
Open on SEC EDGAR
Roger AdsettChief Operating Officer
4
Filed Feb 4, 2026Period of report Feb 3, 20260001685904-26-000006
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleFeb 3, 2026
Common StockF1791$156.17$123.53K106,810Direct
Filing footnotes · 1
  1. F1Shares sold to satisfy tax withholding obligations upon the vesting of Restricted Stock Units and to cover related broker fees.
Open on SEC EDGAR
Sara BonsteinChief Financial Officer
4
Filed Feb 4, 2026Period of report Feb 3, 20260001604019-26-000006
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleFeb 3, 2026
Common StockF1748$156.34$116.94K79,758Direct
Filing footnotes · 1
  1. F1Shares sold to satisfy tax withholding obligations upon the vesting of Restricted Stock Units and to cover related broker fees.
Open on SEC EDGAR
William LewisDirector · Chair and CEO
4
Filed Feb 4, 2026Period of report Feb 3, 20260001402051-26-000011
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleFeb 3, 2026
Common StockF13,009$156.34$470.43K303,882Direct
Filing footnotes · 1
  1. F1Shares sold to satisfy tax withholding obligations upon the vesting of Restricted Stock Units and to cover related broker fees.
Open on SEC EDGAR
William LewisDirector · Chair and CEO
4Rule 10b5-1 plan disclosed
Filed Jan 22, 2026Period of report Jan 20, 20260001402051-26-000009
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleJan 20, 2026
Common StockF1F21,006$156.80$157.74K316,584Direct
SaleJan 20, 2026
Common StockF1F31,243$158.37$196.85K315,341Direct
SaleJan 20, 2026
Common StockF1F45,967$158.99$948.69K309,374Direct
SaleJan 20, 2026
Common StockF1F52,229$159.85$356.31K307,145Direct
SaleJan 20, 2026
Common StockF1F6254$160.70$40.82K306,891Direct
Filing footnotes · 7
  1. F1This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on September 4, 2025 in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended.
  2. F2This is the weighted average sales price representing 1,006 shares sold at prices ranging from $156.53 to $157.50 per share. The Reporting Person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.
  3. F3This is the weighted average sales price representing 1,243 shares sold at prices ranging from $157.54 to $158.53 per share. The Reporting Person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.
  4. F4This is the weighted average sales price representing 5,967 shares sold at prices ranging from $158.55 to $159.52 per share. The Reporting Person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.
  5. F5This is the weighted average sales price representing 2,229 shares sold at prices ranging from $159.55 to $160.32 per share. The Reporting Person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.
  6. F6This is the weighted average sales price representing 254 shares sold at prices ranging from $160.58 to $160.76 per share. The Reporting Person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.
  7. F7The options became exercisable based on the following vesting schedule: 25% vested on the first anniversary of the grant date and an additional 12.5% vested on each sixth month anniversary date thereafter through the fourth anniversary of the date of grant.
Open on SEC EDGAR
William LewisDirector · Chair and CEO
4Rule 10b5-1 plan disclosed
Filed Jan 13, 2026Period of report Jan 12, 20260001402051-26-000007
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleJan 12, 2026
Common StockF1F23,974$167.73$666.56K322,132Direct
SaleJan 12, 2026
Common StockF1F37,176$168.63$1.21M314,956Direct
SaleJan 12, 2026
Common StockF1F46,996$169.57$1.19M307,960Direct
SaleJan 12, 2026
Common StockF1F5160$170.24$27.24K307,800Direct
SaleJan 12, 2026
Common StockF1F6297$171.31$50.88K307,503Direct
SaleJan 12, 2026
Common StockF1F7297$172.36$51.19K307,206Direct
SaleJan 12, 2026
Common StockF1315$174.86$55.08K306,891Direct
Filing footnotes · 8
  1. F1This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on September 4, 2025, in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended.
  2. F2This is the weighted average sales price representing 3,974 shares sold at prices ranging from $167.11 to $168.02 per share. The Reporting Person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.
  3. F3This is the weighted average sales price representing 7,176 shares sold at prices ranging from $168.11 to $169.10 per share. The Reporting Person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.
  4. F4This is the weighted average sales price representing 6,996 shares sold at prices ranging from $169.11 to $170.08 per share. The Reporting Person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.
  5. F5This is the weighted average sales price representing 160 shares sold at prices ranging from $170.12 to $170.89 per share. The Reporting Person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.
  6. F6This is the weighted average sales price representing 297 shares sold at prices ranging from $171.21 to $171.52 per share. The Reporting Person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.
  7. F7This is the weighted average sales price representing 297 shares sold at prices ranging from $172.26 to $172.42 per share. The Reporting Person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.
  8. F8The options became exercisable based on the following vesting schedule: 25% vested on the first anniversary of the grant date and an additional 12.5% vested on each sixth month anniversary date thereafter through the fourth anniversary of the date of grant.
Open on SEC EDGAR
Martina M.D. FlammerChief Medical Officer
4Rule 10b5-1 plan disclosed
Filed Jan 13, 2026Period of report Jan 9, 20260001796960-26-000006
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleJan 9, 2026
Common StockF11,887$186.19$351.34K84,907Direct
Filing footnotes · 1
  1. F1This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on February 27, 2025 in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended.
Open on SEC EDGAR
Michael Alexander SmithChief Legal Officer
4
Filed Jan 8, 2026Period of report Jan 6, 20260001870278-26-000004
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleJan 8, 2026
Common StockF11,053$174.17$183.40K57,037Direct
SaleJan 7, 2026
Common StockF1709$175.07$124.12K58,090Direct
SaleJan 6, 2026
Common StockF11,396$173.33$241.97K58,799Direct
Filing footnotes · 1
  1. F1Shares sold to satisfy tax withholding obligations upon the vesting of Restricted Stock Units and to cover related broker fees.
Open on SEC EDGAR
Martina M.D. FlammerChief Medical Officer
4Rule 10b5-1 plan disclosed
Filed Jan 8, 2026Period of report Jan 6, 20260001796960-26-000004
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleJan 8, 2026
Common StockF5F71,660$173.87$288.62K90,045Direct
SaleJan 8, 2026
Common StockF13,251$174.17$566.23K86,794Direct
SaleJan 7, 2026
Common StockF5F61,434$175.84$252.15K91,705Direct
SaleJan 6, 2026
Common StockF1F24,783$173.47$829.71K98,541Direct
SaleJan 6, 2026
Common StockF1F32,830$174.21$493.01K95,711Direct
SaleJan 6, 2026
Common StockF1F4957$175.01$167.48K94,754Direct
SaleJan 6, 2026
Common StockF51,615$173.33$279.93K93,139Direct
Filing footnotes · 8
  1. F1This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on February 27, 2025 in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended.
  2. F2This is the weighted average sales price representing 4,783 shares sold at prices ranging from $172.89 to $173.87 per share. The Reporting Person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.
  3. F3This is the weighted average sales price representing 2,830 shares sold at prices ranging from $173.92 to $174.80 per share. The Reporting Person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.
  4. F4This is the weighted average sales price representing 957 shares sold at prices ranging from $174.97 to $175.12 per share. The Reporting Person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.
  5. F5Shares sold to satisfy tax withholding obligations upon the vesting of Restricted Stock Units and to cover related broker fees.
  6. F6This is the weighted average sales price representing 1,434 shares sold at prices ranging from $175.72 to $176.00 per share. The Reporting Person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.
  7. F7This is the weighted average sales price representing 1,660 shares sold at prices ranging from $173.87 to $173.90 per share. The Reporting Person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.
  8. F8The options became exercisable based on the following vesting schedule: 25% vested on the first anniversary of the grant date and an additional 12.5% vested on each sixth month anniversary date thereafter through the fourth anniversary of the date of grant.
Open on SEC EDGAR
Roger AdsettChief Operating Officer
4
Filed Jan 8, 2026Period of report Jan 6, 20260001685904-26-000004
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleJan 8, 2026
Common StockF12,059$174.17$358.62K107,601Direct
SaleJan 7, 2026
Common StockF1802$175.07$140.41K109,660Direct
SaleJan 6, 2026
Common StockF11,429$173.33$247.69K110,462Direct
Filing footnotes · 1
  1. F1Shares sold to satisfy tax withholding obligations upon the vesting of Restricted Stock Units and to cover related broker fees.
Open on SEC EDGAR
Sara BonsteinChief Financial Officer
4
Filed Jan 8, 2026Period of report Jan 6, 20260001604019-26-000004
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleJan 8, 2026
Common StockF11,447$174.17$252.02K80,506Direct
SaleJan 7, 2026
Common StockF11,678$175.07$293.77K81,953Direct
SaleJan 6, 2026
Common StockF11,517$173.33$262.94K83,631Direct
Filing footnotes · 1
  1. F1Shares sold to satisfy tax withholding obligations upon the vesting of Restricted Stock Units and to cover related broker fees.
Open on SEC EDGAR
William LewisDirector · Chair and CEO
4
Filed Jan 8, 2026Period of report Jan 6, 20260001402051-26-000005
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleJan 8, 2026
Common StockF13,223$174.17$561.35K315,407Direct
SaleJan 7, 2026
Common StockF12,357$175.07$412.64K318,630Direct
SaleJan 6, 2026
Common StockF14,096$173.33$709.96K320,987Direct
Filing footnotes · 1
  1. F1Shares sold to satisfy tax withholding obligations upon the vesting of Restricted Stock Units and to cover related broker fees.
Open on SEC EDGAR
Martina M.D. FlammerChief Medical Officer
4Rule 10b5-1 plan disclosed
Filed Jan 6, 2026Period of report Jan 2, 20260001796960-26-000002
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleJan 5, 2026
Common StockF4F52,799$169.29$473.84K104,258Direct
SaleJan 5, 2026
Common StockF4F63,205$170.61$546.81K101,053Direct
SaleJan 5, 2026
Common StockF4F72,836$171.19$485.49K98,217Direct
SaleJan 5, 2026
Common StockF4286$171.92$49.17K97,931Direct
SaleJan 5, 2026
Common StockF4F81,820$173.45$315.68K96,111Direct
SaleJan 5, 2026
Common StockF4F9655$174.28$114.15K95,456Direct
SaleJan 5, 2026
Common StockF4F10702$175.73$123.36K94,754Direct
Filing footnotes · 12
  1. F1Represents Restricted Stock Units (RSUs), each representing a contingent right to receive one share of Common Stock, granted pursuant to the Company's Amended and Restated 2019 Incentive Plan, as amended. The RSUs vest as follows: 25% on the first day of the first month following the first anniversary of the date of grant (the Initial Vesting Date) and 25% on each anniversary of the Initial Vesting Date until fully vested.
  2. F10This is the weighted average sales price representing 702 shares sold at prices ranging from $175.54 to $176.12 per share. The Reporting Person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.
  3. F11These stock options were granted under the Company's Amended and Restated 2019 Incentive Plan, as amended. The options become exercisable based on the following vesting schedule: 25% vest on the Initial Vesting Date and an additional 12.5% vest every six months thereafter until fully vested.
  4. F12The options become exercisable based on the following vesting schedule: 25% vest on the first anniversary of the grant date and an additional 12.5% vest on each sixth month anniversary date thereafter through the fourth anniversary of the date of grant.
  5. F2Each RSU was granted on January 2, 2026 for no consideration.
  6. F3Represents RSUs, each representing a contingent right to receive one share of Common Stock, granted pursuant to the Company's Amended and Restated 2019 Incentive Plan, as amended. The RSUs vest in full on February 1, 2029.
  7. F4This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on February 27, 2025 in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended.
  8. F5This is the weighted average sales price representing 2,799 shares sold at prices ranging from $168.88 to $169.69 per share. The Reporting Person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.
  9. F6This is the weighted average sales price representing 3,205 shares sold at prices ranging from $169.91 to $170.90 per share. The Reporting Person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.
  10. F7This is the weighted average sales price representing 2,836 shares sold at prices ranging from $170.91 to $171.89 per share. The Reporting Person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.
  11. F8This is the weighted average sales price representing 1,820 shares sold at prices ranging from $173.05 to $173.87 per share. The Reporting Person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.
  12. F9This is the weighted average sales price representing 655 shares sold at prices ranging from $174.20 to $174.43 per share. The Reporting Person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.
Open on SEC EDGAR
Orlov S Nicole SchaefferChief People Strategy Officer
4Rule 10b5-1 plan disclosed
Filed Jan 6, 2026Period of report Jan 2, 20260001401017-26-000002
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleJan 2, 2026
Common StockF3F431,030$174.28$5.41M98,014Direct
SaleJan 2, 2026
Common StockF3F534,103$175.17$5.97M63,911Direct
SaleJan 2, 2026
Common StockF3F612,832$176.08$2.26M51,079Direct
SaleJan 2, 2026
Common StockF3F79,125$177.17$1.62M41,954Direct
SaleJan 2, 2026
Common StockF3F8200$177.78$35.56K41,754Direct
Filing footnotes · 10
  1. F1Represents Restricted Stock Units (RSUs), each representing a contingent right to receive one share of Common Stock, granted pursuant to the Company's Amended and Restated 2019 Incentive Plan, as amended. The RSUs vest as follows: 25% on the first day of the first month following the first anniversary of the date of grant (the Initial Vesting Date) and 25% on each anniversary of the Initial Vesting Date until fully vested.
  2. F10The options became exercisable based on the following vesting schedule: 25% vested on the first anniversary of the grant date and an additional 12.5% vested on each sixth month anniversary date thereafter through the fourth anniversary of the date of grant.
  3. F2Each RSU was granted on January 2, 2026 for no consideration.
  4. F3This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on August 29, 2025 in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended.
  5. F4This is the weighted average sales price representing 31,030 shares sold at prices ranging from $173.67 to $174.66 per share. The Reporting Person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.
  6. F5This is the weighted average sales price representing 34,103 shares sold at prices ranging from $174.67 to $175.65 per share. The Reporting Person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.
  7. F6This is the weighted average sales price representing 12,832 shares sold at prices ranging from $175.67 to $176.62 per share. The Reporting Person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.
  8. F7This is the weighted average sales price representing 9,125 shares sold at prices ranging from $176.68 to $177.67 per share. The Reporting Person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.
  9. F8This is the weighted average sales price representing 200 shares sold at prices ranging from $177.72 to $177.84 per share. The Reporting Person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.
  10. F9These stock options were granted under the Company's Amended and Restated 2019 Incentive Plan, as amended. The options become exercisable based on the following vesting schedule: 25% vest on the Initial Vesting Date and an additional 12.5% vest every six months thereafter until fully vested.
Open on SEC EDGAR
William LewisDirector · Chair and CEO
4Rule 10b5-1 plan disclosed
Filed Dec 19, 2025Period of report Dec 18, 20250001628280-25-058269
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleDec 18, 2025
Common StockF1F2350$162.26$56.79K314,260Direct
SaleDec 18, 2025
Common StockF1F31,465$163.19$239.07K312,795Direct
SaleDec 18, 2025
Common StockF1F4447$164.24$73.42K312,348Direct
SaleDec 18, 2025
Common StockF1F5697$165.21$115.15K311,651Direct
SaleDec 18, 2025
Common StockF1F61,783$166.60$297.05K309,868Direct
SaleDec 18, 2025
Common StockF1F71,431$167.29$239.39K308,437Direct
SaleDec 18, 2025
Common StockF1F82,175$168.54$366.57K306,262Direct
SaleDec 18, 2025
Common StockF1F91,938$169.58$328.65K304,324Direct
SaleDec 18, 2025
Common StockF1F10362$170.26$61.63K303,962Direct
SaleDec 18, 2025
Common StockF1F1151$171.20$8.73K303,911Direct
Filing footnotes · 12
  1. F1This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on September 4, 2025, in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended.
  2. F10This is the weighted average sales price representing 362 shares sold at prices ranging from $170.02 to $170.91 per share. The Reporting Person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.
  3. F11This is the weighted average sales price representing 51 shares sold at prices ranging from $171.09 to $171.35 per share. The Reporting Person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.
  4. F12The options became exercisable based on the following vesting schedule: 25% vested on the first anniversary of the grant date and an additional 12.5% vested on each sixth month anniversary date thereafter through the fourth anniversary of the date of grant. All options are currently exercisable.
  5. F2This is the weighted average sales price representing 350 shares sold at prices ranging from $161.72 to $162.69 per share. The Reporting Person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.
  6. F3This is the weighted average sales price representing 1,465 shares sold at prices ranging from $162.72 to $163.62 per share. The Reporting Person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.
  7. F4This is the weighted average sales price representing 447 shares sold at prices ranging from $163.75 to $164.73 per share. The Reporting Person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.
  8. F5This is the weighted average sales price representing 697 shares sold at prices ranging from $164.83 to $165.67 per share. The Reporting Person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.
  9. F6This is the weighted average sales price representing 1,783 shares sold at prices ranging from $166.00 to $166.99 per share. The Reporting Person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.
  10. F7This is the weighted average sales price representing 1,431 shares sold at prices ranging from $167.00 to $167.95 per share. The Reporting Person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.
  11. F8This is the weighted average sales price representing 2,175 shares sold at prices ranging from $168.01 to $169.00 per share. The Reporting Person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.
  12. F9This is the weighted average sales price representing 1,938 shares sold at prices ranging from $169.01 to $170.00 per share. The Reporting Person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.
Open on SEC EDGAR

P and S transaction codes only. Grants, gifts, option exercises, tax withholding, and Form 144 notices are not counted as purchases or sales. A row whose filed price fails a plausibility check, or that is not common stock, is listed but left out of the values; a trade reported by several filers is counted once.